This review will provide evidence on the effectiveness and safety of discontinuing diuretics, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/direct renin inhibitors, NSAIDs, metformin and sulfonylureas in relation to AKI. The gene discussed is ACE; the disease is acute kidney injury.